Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2014
07/03/2014WO2014106261A1 Wound and bandage protection system and method
07/03/2014WO2014106208A1 Targeted conjugates encapsulated in particles and formulations thereof
07/03/2014WO2014106116A2 Delivery of biologic therapeutics
07/03/2014WO2014106050A1 Compositions comprising lithium
07/03/2014WO2014106048A2 Liquid topical pharmaceutical nano-emulsion formulations
07/03/2014WO2014106016A1 Multi-polymer compositions for transdermal drug delivery
07/03/2014WO2014106014A1 Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
07/03/2014WO2014106009A1 Compositions and methods for transdermal delivery of non-steroidal anti-inflammatory agents
07/03/2014WO2014105877A1 Low viscosity meta-stable photoprotection composition
07/03/2014WO2014105783A1 Compositions and methods for transdermal delivery of amphetamine and clonidine
07/03/2014WO2014105644A1 Nanoparticle compositions of albumin and paclitaxel
07/03/2014WO2014105613A1 Sunscreen compositions having synergistic combination of titanium dioxide uv filters
07/03/2014WO2014105575A1 Transdermal dosage form for low-melting point active agent
07/03/2014WO2014105446A1 Methods and compositions for administration of oxybutynin
07/03/2014WO2014104989A1 Pharmaceutical compositions comprising aripiprazole
07/03/2014WO2014104929A1 Pharmaceutical composition for treatment of hiv infections
07/03/2014WO2014104868A1 Detoxifying, antimicrobial molecular complex
07/03/2014WO2014104844A1 Microgranular formulation including coagulation unit comprising discontinuous phase and continuous phase
07/03/2014WO2014104840A1 Novel microgranular formulation
07/03/2014WO2014104822A1 Method for producing microspheres using methyl propionate
07/03/2014WO2014104791A1 Sustained-release lipid pre-concentrate of gnrh analogues and pharmaceutical composition comprising the same
07/03/2014WO2014104788A1 Sustained-release lipid pre-concentrate of anionic pharmacologically active substances and pharmaceutical composition comprising the same
07/03/2014WO2014104784A1 Sustained-release lipid pre-concentrate of cationic pharmacologically active substance and pharmaceutical composition comprising the same
07/03/2014WO2014104671A1 Pharmaceutical composition with improved stability, containing temozolomide, and preparation method therefor
07/03/2014WO2014104670A1 Melt extruded pharmaceutical composition for controlling release, and medicine for oral administration including same
07/03/2014WO2014104617A1 Patch kit for treating infectious and non-infectious inflammatory disease, and use therefor
07/03/2014WO2014104412A1 Injectable depot formulation comprising optically active tolvaptan and process of producing the same
07/03/2014WO2014104316A1 Sphingomyelin-containing supplement
07/03/2014WO2014104230A1 Dialysis agent, and method for producing dialysis agent
07/03/2014WO2014104220A1 Packaging
07/03/2014WO2014103987A1 Dispersion stabilizer for particulate substance and dispersion stabilization method therefor
07/03/2014WO2014103737A1 Water-based carbonated beverage
07/03/2014WO2014103488A1 Nasal influenza vaccine composition
07/03/2014WO2014102824A1 Diclofenac composition
07/03/2014WO2014102788A1 Foamable otic pharmaceutical compositions
07/03/2014WO2014102745A1 High drug load ibuprofen sustained release composition
07/03/2014WO2014102741A2 Pharmaceutical dosage form
07/03/2014WO2014102715A1 Pharmaceutical compositions comprising a biguanide and a low dose antidiabetic agent
07/03/2014WO2014102693A1 Pharmaceutical composition containing a derivative of n-phenylpyrazole and permethrin, and use for the production of a topical veterinary medicament
07/03/2014WO2014102679A1 Novel veterinary pharmaceutical compositions and method for the production thereof
07/03/2014WO2014102678A1 Oil suspension of metronidazole
07/03/2014WO2014102628A1 Stable pharmaceutical composition comprising azilsartan medoxomil
07/03/2014WO2014102539A1 Delivery method using mesoporous silica nanoparticles
07/03/2014WO2014102498A1 Dermatological composition comprising a pde7 inhibitor in a dispersed form, method for the production thereof, and use of same
07/03/2014WO2014102497A1 Dermatological composition comprising a pde7 inhibitor in a solubilised form, production method thereof, and use of same
07/03/2014WO2014102253A1 Monolithic dosage form for the modified release of an active ingredient combination
07/03/2014WO2014101986A1 Dry granulation process for producing tablet compositions of metformin and compositions thereof
07/03/2014WO2014101743A1 Freeze-dried excipient and preparation method thereof
07/03/2014WO2014101356A1 Gamabufotalin liposome, preparation method therefor and applicationthereof
07/03/2014WO2014101291A1 Soft-shell crustacean active product rich in calcium invertase
07/03/2014WO2014101115A1 Montelukast sodium tablet composition and preparation method thereof
07/03/2014WO2014101038A1 Method for preparing drug-loaded microspheres
07/03/2014WO2014045307A3 Pharmaceutical composition
07/03/2014WO2013190241A3 Multi-compartment material for the thermally stimulated delivery of substances of interest, preparation method thereof and uses of same
07/03/2014WO2013189800A9 Cisatracurium and beta-cyclodextrin derivative compositions
07/03/2014WO2013135359A8 Targeting aminoacid lipids
07/03/2014US20140188057 Transdermal dosage form for low-melting point active agent
07/03/2014US20140188056 Compositions and methods for transdermal delivery of non-steroidal anti-inflammatory agents
07/03/2014US20140188042 Implantable delivery device system for delivery of a medicament to a bladder
07/03/2014US20140187855 Methods, compositions and kits for surgical repair
07/03/2014US20140187646 Geranylgeranylacetone formulations and retinal and systemic delivery thereof
07/03/2014US20140187644 Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
07/03/2014US20140187642 Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide f2 alpha agonists
07/03/2014US20140187638 Phenylbutyrate in rectal form for the treatment of a motor neuron disease or a metabolic disease
07/03/2014US20140187629 Use of Bethanechol for Treatment of Xerostomia
07/03/2014US20140187614 Amino lipids, their synthesis and uses thereof
07/03/2014US20140187599 Methods for treating diseases using isoindoline compounds
07/03/2014US20140187582 Solid dispersions of amorphous paroxetine mesylate
07/03/2014US20140187578 Pharmaceutical Topical Compositions
07/03/2014US20140187560 Bromocriptine formulations
07/03/2014US20140187538 Lorcaserin hydrochloride
07/03/2014US20140187523 Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
07/03/2014US20140187517 Method for treating intestinal diseases presenting at least one inflammatory component
07/03/2014US20140187497 Ocular Drug Delivery Devices
07/03/2014US20140187490 Val (8) GLP-1 Composition and Method for Treating Functional Dyspepsia and/or Irritable Bowel Syndrome
07/03/2014US20140187486 Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
07/03/2014US20140187481 Transdermal Pharmaceutical Delivery Composition
07/03/2014US20140186515 Dual drug dosage forms with improved separation of drugs
07/03/2014US20140186514 Delayed release rasagiline formulation
07/03/2014US20140186471 Composition for inhibition of cathepsin k
07/03/2014US20140186458 Dietary beverage
07/03/2014US20140186453 Therapeutic Polymeric Nanoparticles with mTOR Inhibitors and Methods of Making and Using Same
07/03/2014US20140186452 Process for Preparing Therapeutic Nanoparticles
07/03/2014US20140186450 Gastroresistant pharmaceutical formulations containing rifaximin
07/03/2014US20140186449 Controlled release preparation
07/03/2014US20140186448 Controlled release preparation
07/03/2014US20140186446 Delivery of Biologic Therapeutics
07/03/2014US20140186445 Method for making customised nanoparticles, nanoparticles and uses thereof
07/03/2014US20140186444 Drug formulations having improved pharmacokinetic properties
07/03/2014US20140186442 Topical Minocycline Compositions and Methods of Using the Same
07/03/2014US20140186441 Composites for Osteosynthesis
07/03/2014US20140186440 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
07/03/2014US20140186439 Stable compositions of famotidine and ibuprofen
07/03/2014US20140186437 Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
07/03/2014US20140186435 Soluble tumor necrosis factor receptor (stnf-r) used as a targeting agent to treat arthritis and other diseases
07/03/2014US20140186431 Combined mesenchymal stem cell transplantation and targeted delivery of vegf for treatment of myocardial infarction
07/03/2014US20140186430 Cochleate compositions directed against expression of proteins
07/03/2014US20140186428 Patch and method for producing the same
07/03/2014US20140186427 Orodispersible films for the manufacturing of individualised medicine or for large scale production
07/03/2014US20140186423 Transdermal Patch Having Ultrasound Transducer for Administering Thrombolytic Reagents to Patients Having a Protein Misfolding Disease
1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 2991